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Abstract 
The ubiquitin-proteasome system (UPS) 
regulates diverse cellular pathways by the 
timely removal (or processing) of proteins. 
Here we review the role of structural disorder 
and conformational flexibility in the different 
aspects of degradation. First, we discuss 
posttranslational modifications within 
disordered regions that regulate E3 ligase 
localization, conformation and enzymatic 
activity, and also the role of flexible linkers in 
mediating ubiquitin transfer and reaction 
processivity. Next we review well-studied 
substrates and discuss that substrate elements 
(degrons) recognized by E3 ligases are highly 
disordered: short linear motifs recognized by 
many E3s constitute an important class of 
degrons and these are almost always present 
in disordered regions. Substrate lysines 
targeted for ubiquitination are also often 
located in neighboring regions of the E3 
docking motifs and are therefore part of the 
disordered segment. Finally, biochemical 
experiments and predictions show that 
initiation of degradation at the 26S 
proteasome requires a partially unfolded 
region to facilitate substrate entry into the 
proteasomal core. 
 
Introduction 
Many cellular pathways and regulatory 
networks require spatial and temporal control 
of effector protein levels. Regulated 
degradation mediated by the ubiquitin-
proteasome system (UPS) is an important 
post-translational mechanism that helps to 
achieve precise fine-tuning of protein levels 
and is being increasingly linked to more and 
more pathways. The UPS is the major 
intracellular degradation pathway that has 
evolved into a complex system consisting of 
several hundred dedicated components (1). 
Important examples of regulated degradation 
include cell cycle regulatory proteins (e.g., 
cyclins, cyclin-dependent kinase inhibitors, 
etc.) that need to be degraded or inactivated 
before cell-cycle checkpoint mechanisms 
decide upon progress (2,3). Transcription 
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factors (e.g., mammalian Myc, Jun, E2-F, p53, 
etc.) that activate gene expression triggered by 
specific stimuli are usually maintained at low 
levels (4,5); further, the ubiquitin system also 
triggers processing (by limited proteolysis) 
and activation of transcription factors such as 
NFκB (6). Cell surface growth factor/hormone 
receptors undergo internalization and 
degradation to switch off signaling inputs (7-
12). The UPS also tightly regulates other key 
intracellular effectors (e.g., Smad proteins, 
Bcl-2) of signaling pathways (13-15). Not 
surprisingly, defects in regulated degradation 
are being linked to increasing numbers of 
diseases, including neurodegeneration and 
cancer, making the UPS very attractive for 
drug design (16-19). 
 
Ubiquitination is organized as a cascade of E1 
(ubiquitin-activating), E2 (ubiquitin-
conjugating) and E3 (ubiquitin ligase) 
enzymes. The pathway is strongly conserved 
from yeast to mammals. The E1-E2-E3 axis 
has a pyramidal structure, with 2 E1 proteins 
(in human), 30-40 E2 enzymes and >600 E3 
ligases (20). E3s are sub-classified into major 
groups based on their subunit organization and 
domain composition (Figure 1) (21,22) and 
they are responsible for detecting and binding 
mis-folded/mis-aggregated polypeptides 
(protein quality control (23)) or to specific 
target substrates for regulated (programmed) 
degradation. 
 
Current challenges in studying UPS-
mediated regulated degradation 
One of the current challenges is the 
identification of substrates for E3 ligases, 
addressed by several large-scale strategies 
recently (24-29). The other crucial aspect is 
the detailed characterization of specific 
elements (degrons) that the E3 ligases detect 
in their substrates (30). Furthermore, there are 
multiple regulatory mechanisms (cellular 
localization, post-translational modification 
(PTM) status, conformational state, etc.) that 
need to be outlined (31,32). These regulatory 
mechanisms act both on the E3 ligase and on 
substrates and connect regulated degradation 
with signaling outcomes. For example, E3s 
are held in inactive conformations and require 
phosphorylation of defined residues to trigger 
conformational activation of enzymatic 
activity (33,34). On the substrate side, the 
phosphorylation profile of degrons and their 
neighborhood play important roles in degron 
recognition by E3s. We have recently 
analyzed the role of structural disorder in 
enabling E3 ligase ubiquitination mechanisms 
(20) and also analyzed known degrons in 
experimentally validated substrates for 
structural disorder (35). In this minireview, we 
focus on the relationship of protein (structural) 
disorder with: (i) E3 regulation and function; 
and, (ii) substrate degrons that specify 
recognition by E3 ligases for regulated 
turnover, and outline the functional 
advantages conferred by the use of disorder in 
regulated protein degradation. 
 
PTMs in disordered regions regulate the 
subcellular localization and activity of E3 
ligases 
E3 ligases determine specificity in the UPS by 
selecting substrates for regulated degradation. 
Diverse mechanisms regulate E3 activity and 
prevent unnecessary protein degradation. 
Phosphorylation has been well studied in this 
context (although diverse PTMs may be used). 
Using phosphorylation as a trigger allows 
degradation to be linked to signaling pathways 
and to facilitate signal integration. Structural 
disorder has direct and indirect consequences 
on the cellular localization, stability and 
activity of E3s. It has been demonstrated that 
disordered segments are enriched both in short 
and linear peptide motifs (SLiMs) and in 
phosphorylation sites that regulate SLiM 
functions, such as cellular localization, 
binding interactions and catalytic activity (36). 
PTMs in disordered regions act 
combinatorially and allow complex regulatory 
decisions (37). How do these mechanisms 
regulate E3 function? 
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MDM2 is a well-characterized E3 that 
regulates p53 (38). Multi-site phosphorylation 
of MDM2 occurs in several disordered 
segments within residues 114-294. Akt-
mediated phosphorylation of S166 and S186 
within close proximity of nuclear localization 
sequences (NLS) and a nuclear export 
sequence (NES) in this disordered region of 
MDM2 stimulates its nuclear entry, which is 
critical in regulating p53 (39,40). BRCA1, 
another well-studied E3 possesses NLSs 
within highly disordered segments and also 
NESs within its N-terminal RING domain: 
phosphorylation-dependent use of these motifs 
changes binding to the nuclear export/import 
machinery and regulates the cellular 
localization of BRCA1 (41). In another 
example, phosphorylation of T24/S29 residues 
in the highly disordered N-terminus of the E3 
ligase Siah2 by p38 MAPK results in its 
exclusion from the nucleus, changing its 
association with its nuclear target prolyl 
hydroxylase 3 (PHD3) (42). However, Siah2 
has both nuclear and cytosolic substrates and 
therefore its localization can affect its 
selection of substrates. The inherent flexibility 
and complexity of the system is underscored 
by multiple phosphosites and docking motifs 
for multiple kinases being located within this 
long disordered region, which allows 
regulation of the same E3 ligase by different 
pathways. Siah2 phosphorylation can also be 
mediated by other kinases, including c-Jun 
NH2-terminal kinase, dual specificity tyrosine-
phosphorylation-regulated kinase 2 and 
homeodomain-interacting protein kinase 2, 
which can phosphorylate similar motifs within 
the disordered N-terminus of Siah2 (43). 
Nucleocytoplasmic shuttling of the yeast E3 
Rsp5 (44), von Hippel-Lindau protein (45), 
hRPF1/Nedd4 (46), the RING-IBR protein 
RBCK1 (47) and muscle-specific E3 
MAFbx/Atrogin 1 (48) via NLS and NES 
signals (often in disordered regions and 
regulated by phosphorylation) are other 
examples of the regulation of E3 activity via 
cellular localization. 
 
PTMs in disordered interdomain linker 
regions regulate the conformational state 
and activity of E3 ligases 
An important mechanism of E3 activation is 
by phosphorylation events that modify critical 
residues in E3s and change E3 conformation 
from inactive to active states. E3 ligases have 
evolved a modular design whereby catalytic 
(ubiquitin-transferring), substrate-targeting 
and other functionalities are often segregated 
into distinct domains (in the case of single-
subunit, ssE3s) or into distinct subunits (in 
multi-subunit, msE3s) (Figure 1). Modularity 
enables regulation of supertertiary structure 
(49), i.e., the relative arrangement of domains 
within multi-domain proteins, where the 
dynamics of flexible inter-domain linkers 
leads to the formation/disruption of intra-
molecular, inter-domain contacts; this appears 
to be a widely used strategy in the regulation 
of E3 ligase activity (50). Again, this links 
degradation to signaling, as kinases are 
frequently used to modify residues in 
disordered/flexible interdomain linkers and 
thereby regulate E3 activity by affecting 
conformational states, as described next. 
 
For example, the E3 ligase Itch is regulated by 
a phosphorylation-induced conformational 
change (33). When unphosphorylated, the 
activity of the Ub-transferring, catalytic 
HECT (Homologous to E6-AP C Terminus) 
domain is inhibited via an intramolecular 
interaction with the WW domain. JNK1 
phosphorylates Itch on three sites within the 
disordered proline-rich region (PRR), altering 
the conformation of WW domain that 
weakens the WW-HECT interaction and 
concomitantly increases catalytic activity of 
the HECT domain. Similarly, the catalytic 
RING domain of c-Cbl is negatively regulated 
by other domains (the tyrosine-kinase binding, 
TKB and linker helix domains) in the protein. 
The linker helix region is predicted partly 
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disordered and contains two critical Tyr 
residues (Y371 and Y368) that mediate 
phosphorylation-induced activation of c-Cbl. 
Y371 and Y368 phosphorylation removes 
negative regulation by inducing a 
conformational transition to an ‘open’, active 
state (34,51). The neuro-protective E3 ligase 
Parkin is also maintained inactive in a closed, 
auto-inhibited conformation by intramolecular 
interactions (52). PTEN induced putative 
kinase 1 (PINK1)-dependent phosphorylation 
of Ser65, which is buried within a pocket 
formed between the disordered linker region 
(residues 77-140) and the N-terminal UBL 
domain (residues 1-76), stimulates opening of 
the intertwined domains, allowing movement 
of UBL and the flexible linker that enables 
catalytic activity (53). Recent structural 
analysis provided detailed insights into 
progressive conformational changes following 
phosphorylation of ubiquitin and the Parkin 
UBL domain, which removes auto-inhibition 
and activates Parkin (54).  Given the 
importance of these phospho-acceptor 
residues, several mutations at these positions 
have been implicated in disease. 
 
Disorder facilitates the dynamics of 
ubiquitin transfer 
Figure 1 shows the domain organization and 
structural design of the major E3 ligase 
subfamilies. The common design principles 
are: (i) modular construction, and (ii) spatial 
separation of substrate binding and E2-Ub 
binding functions. Once active, ‘open’ 
conformations are achieved, ubiquitin transfer 
necessitates conformational flexibility that can 
bring E2-Ub into close proximity to the bound 
substrate such that a suitable 
microenvironment for catalytic Ub-transfer is 
created. This is achieved by linker flexibility 
in case of ssE3s and arises from the flexibility 
of intervening subunits in case of msE3s. 
When crystal structures of representative E3s 
are colored by residue-wise predicted disorder 
scores (Figure 1, bottom), we can identify 
putative flexible regions that may be crucial 
for Ub-transfer dynamics. 
 
Molecular simulations carried out on Cbl 
showed that the flexible linker helix 
connecting the E2-binding RING domain and 
the substrate-binding domain functions as a 
hinge and allows large conformational 
transitions that bring E2-Ub and substrate in 
close proximity (20). HECT E3s also employ 
similar mechanisms: WWP1/AIP5 has a two-
lobed structure in which conformational 
flexibility enabled by rotation about a hinge 
region linking the N and C-terminal lobes 
appears essential for catalytic activity (55). 
Multi-subunit E3 ligases use substrate-binding 
subunits such as VHL-box, SOCS-box or F-
box proteins (Figure 1) that possess two 
domains: one binds the substrate, the other to 
Skp1/DDB1/Elongin B, C subunits. MD 
simulations of nine such substrate-binding 
proteins (Skp2, Fbw7, β-TrCP1, Cdc4, Fbs1, 
TIR1, pVHL, SOCS2, and SOCS4) 
demonstrated that their flexible inter-domain 
linker acts as a hinge, rotating the substrate-
binding domain towards the RING-domain-
bound E2-Ub (located on the other end of the 
msE3 complex), thus optimally positioning 
the bound substrate for ubiquitin transfer (56). 
Furthermore, investigating the cullin subunits 
of CRL complexes also showed that instead of 
being purely rigid scaffolds, the N-terminal 
domains of cullins contain hinge residues 
(highly conserved glycines) that impart 
flexibility (57). Thus, for large multi-subunit 
E3s such as the CRLs, flexibility throughout 
the complex, multi-protein structure is clearly 
evident: in the RING (Rbx1) module (58), the 
cullin scaffold (57), and in the substrate-
binding subunits (56). 
 
Experimental elucidation of the role of 
flexibility in E3 linker regions/subunits mostly 
comes from comparison of multiple crystal 
structures and small-angle X-ray scattering 
(SAXS) experiments (as demonstrated in 
 JBC
 
C
 o
 n
 f 
i d
 e 
n 
t i
 a
 l
 Structural disorder in the regulation of protein degradation 
 5 
CRLs (59)) that highlight multiple linker 
conformations and significant conformational 
transitions to open structural forms that 
promote ubiquitination. Mutational analyses 
of linkers by changing linker length and 
introducing residues with different backbone 
geometries have also enabled elucidation of 
the role of linker flexibility (59). 
 
Structural disorder in the E3 ligase BRCA1 
has been experimentally characterized using 
NMR spectroscopy in conjunction with CD 
spectroscopy and limited proteolysis. BRCA1 
has a ~1500 residue long central disordered 
region (located between its N-terminal RING 
and C-terminal, tandem BRCT domains) that 
functions as a flexible scaffold for multiple 
interaction partners (60). 
 
Disorder facilitates processivity in ubiquitin 
transfer by E3 ligases 
Structural disorder also enables processivity in 
ubiquitination. Ubiquitination enzymes 
undergo large conformational changes during 
their catalytic cycles such as bridging large 
distances so that ubiquitin transfer onto 
appropriate substrate lysine residue(s) can 
take place (50,59,61). Ubiquitination is a 
processive modification since most E3s will 
catalyze multiple rounds of ubiquitin addition 
to the bound substrate. Processivity is a 
kinetic phenomenon widespread among 
enzymes that act on polymeric substrates, 
such as DNA, RNA, polysaccharides, and 
proteins (62). Ubiquitination by E3 ligases is 
often highly processive resulting in either 
multiple monoubiquitination of the substrate 
on proximal Lys acceptor sites, or the buildup 
of a polyubiquitin chain after several 
successive steps of modification (63,64). It 
has been suggested that disordered regions in 
E3s may be instrumental in enabling 
“intramolecular diffusion” of substrate- and 
E2-binding regions of the E3 toward each 
other, resulting in processivity (20). 
 
Structural disorder and folding transitions 
in E3 ligases upon substrate binding 
In addition to disordered/flexible inter-domain 
linkers, disordered E3 regions may also play a 
role in substrate targeting. During previous 
work (see Figure 5 of (20) and references 
therein), we observed two instances where 
disordered segments of E3 ligases undergo 
induced folding upon binding to their 
substrate proteins. The interaction between the 
E3 ligase SMURF1 and its substrate SMAD1 
(PDB 2LAZ) is an instance of co-folding (or 
synergistic folding) between two disordered 
regions. Interaction between the E3 ligase 
RING2 and RYBP (PDB 3IXS) is another 
example. 
 
Substrate regions harboring E3 recognition 
motifs are highly disordered 
Next we survey substrates that undergo UPS-
mediated regulated degradation and the nature 
of the specific determinants that E3 ligases 
recognize on their targets. Yeast has around 
100 E3 ligases and this number increases to 
~600 in higher eukaryotes, including humans 
(65). These 600 ligases are responsible for 
targeting, in principle, the entire proteome. An 
important but unanswered question is the 
nature of the degron that is recognized by 
these E3s. The name degron has been coined 
for substrate elements that confer metabolic 
instability (66). We discuss results 
demonstrating that degradation-specifying 
elements are distributed within the substrate 
(“distributed” degron architecture) and that 
many currently identified degrons are closely 
associated with disordered protein regions. 
 
A number of E3 ligases (the precise fraction 
of which is unknown) recognizes short, linear 
(peptide) motifs on their target proteins (30). 
We refer to these as “primary degrons”, since 
they mediate the first step in regulated 
degradation (35). We collected and analyzed 
28 distinct primary degron types from the 
literature and from the ELM database (of 
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experimentally verified SLiMs) (67). Primary 
degrons are typical SLiMs (67): they are short 
(3-15 residues) sequences, conserved among 
orthologous proteins and contain specificity 
determinants that enable recognition by the 
substrate-targeting domains/subunits of E3 
ligases. The D-box and KEN motifs were the 
first such degrons to be characterized in cell-
cycle regulatory proteins (68); they are 
recognized by the anaphase-promoting 
complex/cyclosome (APC/C), a multi-subunit 
E3 that regulates cell cycle progression in 
eukaryotes (69,70). Primary degrons are 
docking motifs for E3 ligases and initiate 
substrate entry into the UPS. 
 
What kinds of substrates are regulated by 
these degrons? Our recently compiled dataset 
comprises 157 substrates (containing a total of 
171 experimentally validated instances 
corresponding to the 28 degron types). These 
proteins are involved in a wide variety of 
pathways, such as cell-cycle checkpointing, 
apoptosis, transcriptional regulation, etc. 
(Figure 2). Based on our analysis of the 171 
primary degron instances (35), we detected a 
significant correlation between the location of 
these primary degrons and intrinsically 
disordered substrate regions (Figure 2). 
Almost 80% of known degron instances are 
present in disordered interdomain linkers or in 
disordered regions outside domains. The 
remainder localized to surface (mostly 
unstructured) loops of folded domains. Not 
surprisingly, the primary degron region could 
be observed in PDB structures of unbound 
(free) substrates for only 1 out of 157 
substrates (IKK-beta, residues 34-NQETGE-
39, PDB ID: 4E3C). In all other structures, 
either the highly disordered region 
encompassing the degron was not included in 
the crystallization construct (as is often done 
to facilitate crystallization), or missing 
electron density was observed for the degron 
and its neighborhood. 
 
Disordered primary degrons are regulated 
by PTMs within degrons and their flanking 
regions 
PTMs such as phosphorylation often regulate 
primary degron recognition: many degrons are 
turned on/off after modification of one (or 
more) residues. The CBL family of E3s target 
protein tyrosine kinases via the recognition of 
[DN]xpY[ST]xxP (‘x’ indicates any residue, 
‘p’ indicates phosphorylation) and DpYR 
phospho-tyrosine motifs (71,72). 
Phosphodegrons are also well-known 
recognition sites for members of the F-box 
family (73), that form multi-subunit, S phase 
kinase-associated protein 1 (Skp1)-cullin 1 
(Cul1)-F-box protein (SCF) complexes. The 
F-box family functions as substrate adaptors 
in the context of SCF complexes and mediates 
the degradation of many regulatory proteins. 
Phosphorylation-mediated on/off switching of 
degradation is a common strategy in substrates 
controlled by SCF E3 ligases. For example, 
SCF-βTrCP binds the consensus 
DpSGx{2,3}[pST] that is activated after 
double phosphorylation, SCF-Fbw7 binds 
[LIVMP]x{0,2}(pT)Pxx([pST]) sequences 
and SCF-Skp2 targets [DE]x(pT)PxK (74,75). 
Structural disorder facilitates deposition of 
PTMs and it can also be argued that multiple 
modifications within a restricted region would 
benefit from the structural 
plasticity/malleability offered by disordered 
segments (76). 
 
Several examples are known where degrons 
with multiple phosphorylation sites can be 
targeted by multiple kinases, which adds 
increased regulatory complexity to substrate 
recognition. For example, cyclin-dependent 
kinase 2 and glycogen synthase kinase 3 
phosphorylate different residues of the cyclin 
E degron (77). In certain cases, one (or 
multiple) priming phosphorylations in degron-
flanking residues are necessary before 
phosphorylation of the degron itself can take 
place; such priming events have been shown 
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to be critical for substrates such as c-Jun (78), 
β-catenin (79), and Yes-associated protein 
transcriptional coactivator (80). Priming 
phosphorylations sequentially create docking 
sites for downstream kinases, and it is highly 
likely that local structural disorder facilitates 
multiple interactions (multiple 
kinase/phosphatase pairs) required for the 
regulation of such events. 
 
The use of PTMs to (in)activate substrate/E3 
recognition can also confer structural 
advantages. Phosphorylation in disordered 
regions can modulate local conformational 
preferences such that bound-state-like pre-
structuring is observed (81). Thus priming 
modifications in disordered regions can serve 
to achieve specificity for E3 recognition, 
using a signaling event as a trigger and 
thereby achieve temporal and signal-
dependent binding specificity. 
 
Multiple degrons present in disordered 
segments increase avidity of interaction 
Avidity in E3-substrate interactions can be 
enhanced by multiple degrons in a disordered 
segment. Sic1 contains multiple sub-optimal 
phosphodegrons that have evolved an 
ultrasensitive switch-like response such that 
phosphorylation of a certain defined number 
of degrons is required before E3 binding 
becomes stable enough (82). The creation of 
such an intricate docking network within 
phosphorylation clusters requires significant 
structural plasticity to ensure a functional 
system. Other examples of polyvalent 
cooperative interactions facilitated by 
disordered regions can be seen in the multiple 
Ser/Thr-rich degrons of the E3 ligase Cul3-
HIB/SPOP that are clustered in disordered 
substrate regions, and whose in vivo 
cooperativity appears important for E3 
binding and degradation (83). 
 
Ubiquitin-acceptor lysines on substrates 
and correlation with disordered regions 
Following substrate recognition and binding, 
E3-E2 pairs catalyze Ub transfer onto 
substrate lysines. Ubiquitinated lysines that 
are linked to proteasomal degradation have 
been termed as “secondary degron(s)” (35). 
The identity and characteristics of selected 
lysines are not fully understood. Disordered 
substrates such as p27 and p21 undergo non-
selective Lys modifications that lead to 
degradation. For other substrates, the 
geometry of the E3-E2 machinery should lead 
to preferential orientation and selection of 
defined surface regions based on an accessible 
search radius (ubiquitination zone (84-86)) 
containing one or more Lys. In recent 
analyses, we observed that degradation-linked, 
ubiquitinated lysines were often missing from 
PDB electron density maps, and many were 
predicted to fall into locally disordered 
regions (35). This leads us to speculate that a 
conformationally fluctuating surface/region 
should increase the probability of fruitful Ub-
transfer to multiple substrate Lys. The APC/C 
was shown to prefer lysines in disordered 
regions for ubiquitination (87). Similar 
observations were also made by 
bioinformatics studies suggesting a bias for 
degradation-linked ubiquitination sites to be 
more disordered compared to unmodified 
lysines (88). Ubiquitinated proteins are 
targeted to the 26S proteasome for 
degradation, and a higher intrinsic flexibility 
of segments containing multiple ubiquitinated 
Lys would also serve to better engage the Ub-
receptors located on the regulatory subunits of 
the proteasome with higher avidity 
interactions (89). 
 
Substrates require a disordered initiation 
site for efficient degradation by the 26S 
proteasome 
Detailed biochemical analyses suggested that 
ubiquitination is necessary but not sufficient 
for proteasome-mediated degradation. For 
that, a disordered (or partially unfolded) 
region on the substrate is required, because 
substrates without this disordered degradation 
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initiation site (we term it the “tertiary degron” 
(35)) are not effectively degraded, despite 
association with the proteasome (90,91). The 
function of this disordered region is to initiate 
productive proteasomal engagement of the 
substrate and subsequent ATP-dependent 
unfolding. Because the ubiquitin receptors on 
the 19S regulatory particle of the proteasome 
are located ~70-80 Å away from the ATPase 
unfolding channel, the effective substrate 
requires a disordered region of a minimum of 
20-30 residues in length, located next to the 
poly-ubiquitin tag (92,93). We found that this 
feature distinguishes ubiquitination sites 
involved in degradation and those with 
regulatory functions: nearly 60% of 
degradation-linked sites are located in the 
immediate vicinity (within 0-10 residues) of a 
long disordered region (LDR, of at least 20 
consecutive disordered residues), whereas the 
equivalent fraction is only 20-30% in the case 
of ubiquitinated lysines that include non-
degradation, regulatory functions (35). 
Further, degradation efficiency drops sharply 
when the two sites (site of ubiquitin tagging 
and the disordered segment) are gradually 
separated (91), and paralogs lacking a local 
LDR are often involved in signaling rather 
than degradation (94). Actually what may 
happen is that degradation becomes less 
efficient for these paralogs, but does not stop 
altogether; this ensures control of signaling 
decay with time. 
 
In this context, it has been shown that the 
requirement for a disordered degradation 
initiation site appears to be the most important 
criterion even for ubiquitin-independent 
proteasomal substrates (examples include the 
transcriptional regulator Rpn4, thymidylate 
synthase and ornithine decarboxylase) (95,96). 
 
Conclusions and Perspectives 
Alongside transcriptional and translational 
control, regulated degradation is a primary 
mechanism of the cell to control the 
functioning of its extremely complex 
collection of proteins, i.e., the proteome. 
Ubiquitin ligases select substrates for 
degradation by the recognition of often 
unknown signals (degrons) within target 
proteins, but nonetheless confer specific 
recognition. Although the area is of significant 
contemporary interest, much work is required 
to identify the precise nature of these signals 
and details about their operation. 
 
Here we have reviewed multiple lines of 
evidence suggesting the involvement of 
structural disorder and conformational 
flexibility in this pathway. Structural disorder 
also makes it more difficult to recognize 
degrons in the sequence and structure of 
proteins. We are in the beginning of 
unraveling the complex regulatory interplay 
between different signals and post-
translational modifications in physiological 
and pathological functions. Dedicated 
bioinformatics, modeling, high-throughput 
proteomics and detailed structural studies will 
be required to unravel the complexities 
associated with regulated degradation.
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Figure Legends 
 
Figure 1. Main subclasses of E3 ubiquitin ligases, architectures and structural disorder. 
(Top) Classification table for E3 ligases based on structural and functional domain composition. 
The specific functional characteristics for each subclass are indicated, such as interaction with E2 
and/or with the substrate (‘S’), functioning as a scaffold or adaptor/substrate recognition subunit 
in msE3s. 
(Middle) Representative models (schematic diagrams) of different E3 ligase/E2/substrate 
complexes (numbering corresponds to top panel). The small superscript numbers in the table 
above are linked to the diagrams in this panel. Color scheme: ubiquitin (Ub) and poly-Ub chains 
(orange), ubiquitin-conjugation (E2) enzymes (light pink), E3 ligase (pale green), scaffold 
protein cullin (light violet), adaptor protein (light blue), substrate recognition subunits (pink), 
and substrates (S) (blue). Subunits of APC/C are shown according to their functional class. 
(Bottom) Ribbon diagram of the crystal structure (PDB code: 4A4C) of human CBL (chain A) 
(left), WWP1 HECT domain E3 Ligase (PDB code: 1ND7) (middle) and the multi-subunit SCF 
complex (PDB code: 1LDK) (right). The structures are shown colored by IUPred (97) residue-
wise disorder scores (color scale is shown). IUPred disorder scores range from 0-1; the higher 
the score, greater the predicted disorder. 0.5 and greater indicate disordered residues. 
 
Figure 2. Primary degrons and their major properties. 
(Top left) Pie-chart showing the overlap of substrate primary degron instances (171 
experimentally validated instances from 157 substrates) relative to Pfam domains (98).  (Top 
middle) Pie-chart showing the predicted secondary structure distribution of primary degron 
residues (using PSIPRED (99)). (Top right) Pie-chart showing the major Gene Ontology (GO) 
categories associated with substrates carrying known primary degrons. 
(Bottom) Schematic diagrams of substrate proteins (blue) with the primary degron (yellow) 
indicated. The diagrams show three possible locations of primary degrons relative to domains: 
degron at chain termini, degron in interdomain linker regions and degron within domains. 
Specific examples of proteins corresponding to each category are shown using domain diagrams. 
Primary degron sequences are shown in red. Domains (cylinder) and inter-domain or non-
domain (thick straight line) regions are in grey. 
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